Companies in the cannabis industry need leaders to help navigate a complex and continually evolving regulatory and legal landscape.

loader

Overview

Experience

Resources

News

  • 12.26.2023
    Andrew Kline quoted in Cannabis Business Times—Cannabis Industry to 2023: 'Don’t Let the Door Hit You in the …'
    Andrew Kline was quoted in the Cannabis Business Times in an article that canvassed leading legal and policy experts on their cannabis market expectations for 2024 and thoughts on how the industry fared during 2023. Andrew shared his perspective on the prospects for rescheduling and a Drug Enforcement Administration draft rule in the coming year.
  • 12.05.2023
    Andrew Kline Quoted in Colorado Politics—Jared Polis, Democrat Governors Urge Biden Administration to move Forward on Cannabis 'Rescheduling'
    General News
    Andrew Kline was quoted in "Jared Polis, Democrat Governors Urge Biden Administration to move Forward on Cannabis 'Rescheduling'," an article in Colorado Politics, regarding the Governor of Colorado and other governors urging the Biden administration to reschedule cannabis.
  • 09.06.2023
    Andrew Kline Interviewed by Politico—Biden Becomes Unlikely Weed Savior
    General News
    Andrew Kline was interviewed by Politico and quoted in the Politico Cannabis newsletter in an article about the FDA's recommendation to move marijuana from Schedule I to Schedule III under the Controlled Substances Act. "The president just saved a $30 billion, 450,000 industry," said Andrew Kline, a cannabis attorney with Perkins Coie who spent more than a decade as a federal prosecutor. "This is objectively the largest win we've ever seen in cannabis."
  • 09.01.2023
    Andrew Kline Quoted in Green Market Report—What Could Rescheduling Mean for the Cannabis Industry?
    General News
    Andrew Kline was quoted in "What Could Rescheduling Mean for the Cannabis Industry?," an article in Green Market Report, regarding predictions for what could happen if the Drug Enforcement Agency agrees to reschedule cannabis on the list of federally controlled substances.
  • 06.01.2023
    Perkins Coie Named Among Top Law Firms in 2023 Chambers USA
    Press Releases
    Perkins Coie is proud to announce that it has again been ranked by Chambers & Partners, publishers of Chambers USA: America’s Leading Lawyers for Business, as one of the top law firms in the United States.

Insights

gavel in court

In June 2023, CCSR released a comprehensive report on the classification of cannabis under the Controlled Substances Act and the urgent need for reform. The report details the advantages of descheduling cannabis or rescheduling it at schedule III, IV or V. Perkins Coie is proud to be a member of the CCSR and an author of the report.

LEARN MORE